Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP12012120priorityCriticalpatent/ECSP12012120A/en
Publication of ECSP12012120ApublicationCriticalpatent/ECSP12012120A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a compuestos de pirazol de fórmula (I) y sales farmacéuticamente aceptables de los mismos con actividad de CRTH2, en los que W, L1, L2, X, L3 , Y, R1 y R2 son como se define en la memoria descriptiva y en las reivindicaciones, a su uso como medicamentos y a formulaciones farmacéuticas, que contienen dichos compuestos o que contienen una combinación de dichos compuestos con una o más sustancias activas.The present invention relates to pyrazole compounds of formula (I) and pharmaceutically acceptable salts thereof with CRTH2 activity, wherein W, L1, L2, X, L3, Y, R1 and R2 are as defined in Descriptive specification and in the claims, for use as medicaments and pharmaceutical formulations, containing said compounds or containing a combination of said compounds with one or more active substances.
ECSP120121202012-08-232012-08-23
PIRAZOL COMPOUNDS AS CRTH2 ANTAGONISTS.
ECSP12012120A
(en)
DERIVATIVES OF QUINOLINA, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND AND THE USE OF SUCH IN THE TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISEASES